Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.athoracsur.2013.04.014 http://scihub22266oqcxt.onion/10.1016/j.athoracsur.2013.04.014 C3718051!3718051!23647859     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Thorac+Surg 2013 ; 95 (6): 1885-91 Nephropedia Template TP {{tp|p=23647859|t=2013. Completion Pneumonectomy: Outcomes for Benign and Malignant Indications |pdf=|usr=}}{{23647859}} gab.com Text Completion Pneumonectomy: Outcomes for Benign and Malignant Indications JO: Ann Thorac Surg http://www.kidney.de/pget.php?&tw=1&pmid=23647859 #FOAvip Background: Past series have identified completion pneumonectomy (CP) as a high-risk operation. We evaluated factors affecting outcomes of CP with a selective approach to offering this operation. Methods: We analyzed a prospective institutional database and abstracted information on patients undergoing pneumonectomy. Patients undergoing CP were compared to those undergoing primary pneumonectomy (PP). Results: Between 1/2000 and 2/2011, 211 patients underwent pneumonectomy, of which 35 (17%) were CPs. Ten of 35 (29%) CPs were for benign disease and 25/35 (71%) for cancer. Major perioperative morbidity was seen in 21/35 (60%) with 4 (11%) perioperative deaths. In univariate analysis, postoperative bronchopleural fistula (p=0.05) and benign diagnosis (p=0.07) tended to be associated with perioperative mortality.All 10 patients undergoing CP for benign disease developed a major complication compared to 11/25 (44%) with malignancy, p=0.002. A bronchopleural fistula (4/35, 11%) was more likely to occur in patients undergoing CP shortly after the primary operation (interval between lobectomy and CP; 0.28 vs. 4.5 years; p=0.018) with a trend towards a benign indication for operation (p=0.07). Median survival after CP for benign and malignant indications was 24.3 months and 36.5 months respectively.Comparing CP patients to those undergoing PP (n=176), CP patients were more likely to undergo surgery for benign disease (10/35, 29% vs. 14/176, 8%, p=0.001). Perioperative mortality for PP was 10/176 (5.7%), and was statistically similar to CP (11%). Conclusions: Despite a selective approach, CP remains a morbid operation particularly for benign indications. Rigorous preoperative optimization, ruling out contraindications to surgery and attention to technical detail are recommended. Twit Text FOAVip Completion Pneumonectomy: Outcomes for Benign and Malignant Indications ????Ann Thorac Surg http://www.kidney.de/pget.php?&tw=1&pmid=23647859 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=23647859 #FOAvip English Wikipedia <ref>{{Cite pmid|23647859}}</ref> Completion Pneumonectomy: Outcomes for Benign and Malignant Indications #MMPMID23647859 Puri V; Tran A; Bell JM; Crabtree TD; Kreisel D; Krupnick AS; Patterson GA; Meyers BF Ann Thorac Surg 2013[Jun]; 95 (6): 1885-91 PMID23647859show ga Background: Past series have identified completion pneumonectomy (CP) as a high-risk operation. We evaluated factors affecting outcomes of CP with a selective approach to offering this operation. Methods: We analyzed a prospective institutional database and abstracted information on patients undergoing pneumonectomy. Patients undergoing CP were compared to those undergoing primary pneumonectomy (PP). Results: Between 1/2000 and 2/2011, 211 patients underwent pneumonectomy, of which 35 (17%) were CPs. Ten of 35 (29%) CPs were for benign disease and 25/35 (71%) for cancer. Major perioperative morbidity was seen in 21/35 (60%) with 4 (11%) perioperative deaths. In univariate analysis, postoperative bronchopleural fistula (p=0.05) and benign diagnosis (p=0.07) tended to be associated with perioperative mortality.All 10 patients undergoing CP for benign disease developed a major complication compared to 11/25 (44%) with malignancy, p=0.002. A bronchopleural fistula (4/35, 11%) was more likely to occur in patients undergoing CP shortly after the primary operation (interval between lobectomy and CP; 0.28 vs. 4.5 years; p=0.018) with a trend towards a benign indication for operation (p=0.07). Median survival after CP for benign and malignant indications was 24.3 months and 36.5 months respectively.Comparing CP patients to those undergoing PP (n=176), CP patients were more likely to undergo surgery for benign disease (10/35, 29% vs. 14/176, 8%, p=0.001). Perioperative mortality for PP was 10/176 (5.7%), and was statistically similar to CP (11%). Conclusions: Despite a selective approach, CP remains a morbid operation particularly for benign indications. Rigorous preoperative optimization, ruling out contraindications to surgery and attention to technical detail are recommended. äCompletion Pneumonectomy: Outcomes for Benign and Malignant Indication(epmc).pdf DeepDyve Pubget Overpricing